Avian Influenza A(H5N1) Neuraminidase Inhibition Antibodies in Healthy Adults after Exposure to Influenza A(H1N1)pdm09

We detected high titers of cross-reactive neuraminidase inhibition antibodies to influenza A(H5N1) virus clade 2.3.4.4b in 96.8% (61/63) of serum samples from healthy adults in Hong Kong in 2020. In contrast, antibodies at low titers were detected in 42% (21/50) of serum samples collected in 2009. Influenza A(H1N1)pdm09 and A(H5N1) titers were correlated.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:30

Enthalten in:

Emerging infectious diseases - 30(2024), 1 vom: 26. Jan., Seite 168-171

Sprache:

Englisch

Beteiligte Personen:

Daulagala, Pavithra [VerfasserIn]
Cheng, Samuel M S [VerfasserIn]
Chin, Alex [VerfasserIn]
Luk, Leo L H [VerfasserIn]
Leung, Kathy [VerfasserIn]
Wu, Joseph T [VerfasserIn]
Poon, Leo L M [VerfasserIn]
Peiris, Malik [VerfasserIn]
Yen, Hui-Ling [VerfasserIn]

Links:

Volltext

Themen:

Antibodies, Viral
Clade 2.3.4.4.b
Cross-reactive antibody response
EC 3.2.1.18
Influenza
Influenza A(H1N1)pdm09
Influenza A(H5N1)
Influenza Vaccines
Journal Article
Neuraminidase
Neuraminidase inhibition antibody
Pandemic risk assessment
Respiratory infections
Viruses

Anmerkungen:

Date Completed 28.12.2023

Date Revised 02.01.2024

published: Print

Citation Status MEDLINE

doi:

10.3201/eid3001.230756

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM366381962